Afya Limited - AFYA STOCK NEWS

Afya Limited (Nasdaq: AFYA) has acquired 100% of Cliquefarma, a Brazilian healthtech firm that allows users to compare prices of prescription drugs and healthcare products from over 5,000 pharmacies. The acquisition aims to enhance Afya's Digital Prescription services and leverage Cliquefarma's significant web traffic of 20 million visitors and R$ 43.2 million GMV for 2020, representing 52.9% growth from the previous year. The purchase price is R$ 19 million, mainly in cash, with an additional earn-out potential of R$ 3 million based on product developments.

Afya Limited (Nasdaq: AFYA) reported strong financial results for FY 2020, with an Adjusted Net Revenue of R$1,207.7 million, reflecting a 60.9% YoY increase. Excluding acquisitions, revenue rose 27.6% to R$957.8 million. The Adjusted EBITDA surged by 68.9% to R$563.1 million, achieving a margin of 46.6%. Additionally, the company reported a remarkable Adjusted Net Income of R$390.9 million, up 72.2% YoY. Afya maintained a healthy cash position of R$1 billion and achieved a cash conversion rate of 75.7%. The company continues to focus on digital expansion and strategic acquisitions, bolstering its position in the Brazilian healthcare market.

Afya Limited (Nasdaq: AFYA) announced its acquisition of Medical Harbour for R$ 5 million, paid in cash, representing 3.3x its expected gross revenue for 2021. Medical Harbour provides innovative Educational Health and Medical Imaging Solutions, enhancing anatomy education through a digital platform called Athena Hub, utilized by over 50 universities in Brazil. They also offer services simplifying Radiology and Teleradiology, with over 24,000 downloads across 180 countries. An additional earn-out of R$ 9 million may be paid based on product development and revenue targets.

Afya Limited (Nasdaq: AFYA) announced the acquisition of Medicinae, a Brazilian healthcare technology company, for R$ 5.6 million in cash. This acquisition enhances Afya’s digital health services by integrating Medicinae's financial platform, which simplifies receivables management for healthcare professionals across Brazil. Medicinae boasts over 1,420 users and has witnessed 11x revenue growth since 2018. CEO Virgílio Gibbon emphasized the strategic importance of this acquisition in addressing financial challenges faced by healthcare professionals and expanding service offerings.

Afya Limited (Nasdaq: AFYA) has announced the upcoming release of its fourth quarter 2020 and full-year 2020 unaudited financial results on April 8, 2021, after market close. A conference call and webcast are scheduled for April 9, 2021, at 10:00 AM EDT to discuss these results. Afya is recognized as a leading medical education group in Brazil, offering comprehensive support to medical students and professionals throughout their educational journey.

Afya Limited (Nasdaq: AFYA) has successfully closed its acquisition of iClinic, the leading medical practice management SaaS company in Brazil, through its subsidiary Afya Participações S.A. The acquisition cost R$191.1 million, with 62.6% paid in cash and 37.4% in common shares. iClinic supports over 25,000 monthly active users, facilitating approximately 790,000 consultations each month, including telemedicine services. This strategic move is expected to enhance Afya's digital offerings and empower physicians, thereby solidifying its position in Brazil's healthcare technology market.

Afya Limited (Nasdaq: AFYA) announced that its clinical decision software WhiteBook was ranked among the top 10 apps in Brazil by consumer spending for the fifth consecutive year. The ranking, conducted by App Annie, featured WhiteBook alongside major apps like Tinder and YouTube. WhiteBook aids medical professionals in making quick and accurate clinical decisions, boasting over 161,000 monthly active users and 106,000 subscribers. Additionally, Afya's share buyback program continues, and the company recently received authorization to operate a new undergraduate medicine course.

Afya Limited (Nasdaq: AFYA) has announced a share buyback program, enabling the repurchase of up to 1,015,844 Class A common shares. This program will commence on December 24, 2020, and continue until the earlier of completion or December 31, 2021, depending on market conditions. The buyback aims to support the company's Stock Option Program for executives and will utilize existing funds. The Board of Directors retains the authority to adjust or suspend the program as necessary.

Afya Limited (Nasdaq: AFYA) announced strong financial results for 3Q20, reporting adjusted net revenue of R$313.3 million, a 51.6% year-over-year increase, despite COVID-19 impacts. Adjusted EBITDA reached R$149.3 million, up 63.3%, with a margin expansion of 340 bps to 47.6%. The company's total medical student enrollment grew by 49.8%, and they ended the quarter with R$1.1 billion in cash. Afya completed multiple strategic acquisitions, enhancing its digital health services, and reaffirmed its guidance for 2H20, expecting net revenue between R$600 million and R$640 million.